257 related articles for article (PubMed ID: 27032450)
1. Are early cannulation arteriovenous grafts (ecAVG) a viable alternative to tunnelled central venous catheters (TCVCs)? An observational "virtual study" and budget impact analysis.
Aitken E; Iqbal K; Thomson P; Kasthuri R; Kingsmore D
J Vasc Access; 2016 May; 17(3):220-8. PubMed ID: 27032450
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial and cost-effectiveness analysis of early cannulation arteriovenous grafts versus tunneled central venous catheters in patients requiring urgent vascular access for hemodialysis.
Aitken E; Thomson P; Bainbridge L; Kasthuri R; Mohr B; Kingsmore D
J Vasc Surg; 2017 Mar; 65(3):766-774. PubMed ID: 28236919
[TBL] [Abstract][Full Text] [Related]
3. Impact of Early Cannulation Grafts on Quality and Cost of Care for Patients With End-Stage Renal Disease.
Desai SS
Ann Vasc Surg; 2019 Oct; 60():203-210. PubMed ID: 31200049
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis of the Hemodialysis Reliable Outflow (HeRO) Graft compared to the tunneled dialysis catheter.
Al Shakarchi J; Inston N; Jones RG; Maclaine G; Hollinworth D
J Vasc Surg; 2016 Apr; 63(4):1026-33. PubMed ID: 26826055
[TBL] [Abstract][Full Text] [Related]
5. Immediate access arteriovenous grafts versus tunnelled central venous catheters: study protocol for a randomised controlled trial.
Aitken E; Geddes C; Thomson P; Kasthuri R; Chandramohan M; Berry C; Kingsmore D
Trials; 2015 Feb; 16():42. PubMed ID: 25885054
[TBL] [Abstract][Full Text] [Related]
6. Two-Year Outcomes of Early Cannulation Arteriovenous Grafts for End-Stage Renal Disease.
Desai SS
Ann Vasc Surg; 2019 Aug; 59():158-166. PubMed ID: 31009720
[TBL] [Abstract][Full Text] [Related]
7. Early-Cannulation Arteriovenous Grafts Are Safe and Effective in Avoiding Recurrent Tunneled Central Catheter Infection.
Richarz S; Stevenson K; White B; Thomson PC; Jackson A; Isaak A; Kingsmore DB
Ann Vasc Surg; 2021 Aug; 75():287-293. PubMed ID: 33819582
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of immediate access arteriovenous grafts versus standard grafts for hemodialysis.
Mohapatra A; Yuo TH; Lowenkamp MN; Wagner JK; Dillavou ED; Chaer RA; Avgerinos ED
J Vasc Surg; 2021 Feb; 73(2):581-587. PubMed ID: 32473345
[TBL] [Abstract][Full Text] [Related]
9. Is there an association between central vein stenosis and line infection in patients with tunnelled central venous catheters (TCVCs)?
Aitken E; Honour P; Johnson N; Kingsmore D
J Vasc Access; 2015; 16 Suppl 9():S42-7. PubMed ID: 25751550
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of autogenous arteriovenous fistula, arteriovenous graft, and tunneled-cuffed catheter for hemodialysis in patients with end-stage kidney disease in Southern China.
Wong TS; Chen Q; Zhong Q; Hu B; Feng G; Huang F; Lu J; Yin L; Yu Z; Akinwunmi BO; Huang J; Zhang CJ; Ming WK
J Vasc Access; 2024 May; 25(3):953-962. PubMed ID: 36540049
[TBL] [Abstract][Full Text] [Related]
11. Early cannulation prosthetic graft (Acuseal) for arteriovenous access: a useful option to provide a personal vascular access solution.
Aitken EL; Jackson AJ; Kingsmore DB
J Vasc Access; 2014; 15(6):481-5. PubMed ID: 24811599
[TBL] [Abstract][Full Text] [Related]
12. Hemodialysis tunneled central venous catheters: five-year outcome analysis.
Mandolfo S; Acconcia P; Bucci R; Corradi B; Farina M; Rizzo MA; Stucchi A
J Vasc Access; 2014; 15(6):461-5. PubMed ID: 24811590
[TBL] [Abstract][Full Text] [Related]
13. The use of tunneled central venous catheters: inevitable or system failure?
Aitken EL; Stevenson KS; Gingell-Littlejohn M; Aitken M; Clancy M; Kingsmore DB
J Vasc Access; 2014; 15(5):344-50. PubMed ID: 24532000
[TBL] [Abstract][Full Text] [Related]
14. Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis.
Hall RK; Myers ER; Rosas SE; O'Hare AM; Colón-Emeric CS
Clin J Am Soc Nephrol; 2017 Jun; 12(6):947-954. PubMed ID: 28522655
[TBL] [Abstract][Full Text] [Related]
15. Hemodialysis patients' satisfaction and perspectives on complications associated with vascular access related interventions: are we listening?
Kosa SD; Bhola C; Lok CE
J Vasc Access; 2016 Jul; 17(4):313-9. PubMed ID: 27312766
[TBL] [Abstract][Full Text] [Related]
16. Vascular access for home haemodialysis.
Al Shakarchi J; Day C; Inston N
J Vasc Access; 2018 Nov; 19(6):593-595. PubMed ID: 29562840
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of peripherally inserted central catheter and other venous access devices: A scoping review.
Wang K; Zhong J; Huang N; Zhou Y
J Vasc Access; 2020 Nov; 21(6):826-837. PubMed ID: 31894710
[TBL] [Abstract][Full Text] [Related]
18. Patient-centric analysis of dialysis access outcomes.
Solesky BC; Huber TS; Berceli SA
J Vasc Access; 2010; 11(1):31-7. PubMed ID: 20119923
[TBL] [Abstract][Full Text] [Related]
19. A novel electrospun nano-fabric graft allows early cannulation access and reduces exposure to central venous catheters.
Karatepe C; Aitinay L; Yetim TD; Dagli C; Dursun S
J Vasc Access; 2013; 14(3):273-80. PubMed ID: 23599141
[TBL] [Abstract][Full Text] [Related]
20. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
